Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Device Center Working Out “Nuts And Bolts” Of Interactive Review

This article was originally published in The Gray Sheet

Executive Summary

If all goes as planned, beginning Oct. 1 FDA device reviewers will be taking a new, more interactive approach to product applications, though agency officials are still unsure exactly how the method will work

You may also be interested in...



New Interactive FDA Device Review Is Significant, But Goes Only So Far

An FDA staffer trying to create an informal, "interactive review" process for devices warned companies last week that even under the new system they should not expect extensive discussion without temporarily halting review of an application

New Interactive FDA Device Review Is Significant, But Goes Only So Far

An FDA staffer trying to create an informal, "interactive review" process for devices warned companies last week that even under the new system they should not expect extensive discussion without temporarily halting review of an application

Congress Approves FDA Reform/User Fee Bill In The Nick Of Time

Congress gave final approval last week to a massive FDA bill that renews device and drug user fees for five years and strengthens product safety programs

Related Content

UsernamePublicRestriction

Register

MT024993

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel